| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |